The implementation of SB20 is expected to simplify regulations surrounding prior authorization, potentially reducing delays in obtaining necessary medications for patients suffering from severe medical conditions. By mandating that health insurers expedite determinations within specified timeframes, the bill seeks to ensure that patients receive prompt care, thereby improving health outcomes and patient satisfaction. Additionally, by removing annual prior authorization for chronic maintenance drugs, the bill aims to alleviate the administrative burden on healthcare providers and patients alike, making healthcare more accessible and efficient.
Summary
Senate Bill 20 addresses the issue of prior authorization within the healthcare system, specifically targeting pharmacy benefits managers (PBMs). The bill aims to streamline the prior authorization process for medications that are critically needed to treat serious health conditions, including serious mental illness and chronic health conditions. Under this legislation, prior authorization will no longer be necessary for certain medications, ensuring timely access for patients who require treatment for autoimmune disorders, cancer, serious mental illnesses, or substance use disorders. Moreover, once a prior authorization is granted for chronic maintenance drugs, it will not be required again for three years unless certain conditions arise that necessitate a review.
Contention
While the bill has garnered support from healthcare advocacy groups and some legislators who argue that it prioritizes patient care and medication access, it has also faced criticism. Opponents of the bill express concern about the possible financial implications for insurance companies and worry that eliminating the prior authorization process may lead to increased costs for insurers. There is also apprehension regarding the regulatory power of pharmacy benefits managers, which could arguably diminish the ability of insurers to manage their formularies effectively. Thus, the discussions surrounding SB20 have highlighted the balance between ensuring patient access and maintaining cost control within the healthcare system.